Reverse DCF
What growth does the market imply for KOLTEPATIL?
Working backwards from the current price to find the FCF growth assumption baked in.
reasonable
10.8% implied annual FCF growth
The market's growth assumption looks achievable — it is in line with or below what this company has historically delivered.
Current Price
₹401
Historical Growth
20.0%
FCF Yield
6.31%
Price / FCF
15.8x
Plain English
To justify today's price of $400.85, KOLTEPATIL.NS needs to grow its free cash flow at 10.8% per year for the next 10 years. That is 9.2% slower than its historical growth rate of 20.0%. This looks achievable — the market is not pricing in heroic assumptions. There may be genuine upside if the company executes.
Adjust Assumptions
Growth Scenarios
What the stock is worth at different growth assumptions
| Scenario | FCF Growth | Implied IV | MoS vs Price |
|---|---|---|---|
| Half implied | 5.4% | ₹234 | -41.6% |
| GDP rate | 10.0% | ₹371 | -7.5% |
| Implied | 10.8% | ₹399 | -0.5% |
| Historical | 20.0% | ₹896 | +123.6% |
At Historical Growth Rate
It would take 4 years for KOLTEPATIL to organically grow into today's price assuming its historical FCF growth of 20.0%.
See full DCF analysis
Bear/base/bull scenarios, sensitivity heatmap, Monte Carlo, and more.
Run Full Analysis →This is an analytical tool, not investment advice. Implied growth is a mathematical inversion of the DCF model and depends on WACC and terminal growth assumptions. YieldIQ is not registered with SEBI as an investment adviser.